• Thu. Mar 28th, 2024

Dr. Reddy’s Laboratories Launched New Capsule Approved By USFDA

Dr. Reddy's Laboratories Launched New Capsule Approved By USFDADr. Reddy's Laboratories Launched New Capsule Approved By USFDA

Hyderabad, sept.26 (Hydnow): Dr. Reddy’s Laboratories Ltd. today announced the launch of Dimethyl Fumarate Delayed-Release Capsules, a therapeutic equivalent generic version of Tecfidera® (dimethyl fumarate) Delayed-Release Capsules, approved by the U.S. Food and Drug Administration (USFDA).

The Tecfidera® brand and generic market had U.S. sales of approximately $3.8 billion MAT for the most recent twelve months ending in June 2020 according to IQVIA Health*.

Dr. Reddy’s Dimethyl Fumarate Delayed-Release Capsules are available in 120 mg and 240 mg capsules in bottle count sizes of 14 and 60 capsules, respectively.(Hydnow)

Advertisements

Leave a Reply

Your email address will not be published. Required fields are marked *